Monument Therapeutics Partners with FNIH for Innovative Schizophrenia Treatment Clinical Trial Monument Therapeutics collaborates with the Foundation for NIH to explore a groundbreaking treatment for cognitive issues in schizophrenia, MT1988.

Monument Therapeutics Partners with FNIH for Innovative Schizophrenia Treatment Clinical Trial #United_Kingdom #Manchester #Monument_Therapeutics #FNIH #MT1988